| Code | Description | Claims | Beneficiaries | Total Paid |
| 87426 |
Infectious agent antigen detection, SARS-CoV-2 (COVID-19) |
1,156 |
1,066 |
$50K |
| 84443 |
Thyroid stimulating hormone (TSH) |
2,535 |
2,463 |
$43K |
| 80061 |
Lipid panel |
2,416 |
2,362 |
$33K |
| 80053 |
Comprehensive metabolic panel |
2,939 |
2,849 |
$31K |
| G2023 |
Specimen collection for severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), any specimen source |
1,292 |
1,186 |
$31K |
| 85025 |
Blood count; complete (CBC), automated, and automated differential WBC count |
3,844 |
3,681 |
$30K |
| 83036 |
Hemoglobin; glycosylated (A1C) |
1,340 |
1,305 |
$14K |
| 81000 |
|
3,125 |
3,017 |
$10K |
| 84436 |
|
1,036 |
1,022 |
$7K |
| 84479 |
|
1,010 |
990 |
$7K |
| 82306 |
Vitamin D; 25 hydroxy, includes fraction(s), if performed |
186 |
180 |
$5K |
| 87804 |
Infectious agent antigen detection by immunoassay; Influenza, each type |
298 |
142 |
$3K |
| 82274 |
|
186 |
179 |
$3K |
| 86328 |
|
171 |
165 |
$3K |
| 80074 |
|
22 |
21 |
$1K |
| 86701 |
|
107 |
106 |
$999.05 |
| 86738 |
|
62 |
61 |
$946.90 |
| 82043 |
|
138 |
132 |
$811.93 |
| 87491 |
Infectious agent detection by nucleic acid; Chlamydia trachomatis, amplified probe |
21 |
21 |
$751.51 |
| 36415 |
Collection of venous blood by venipuncture |
191 |
179 |
$650.94 |
| 86696 |
|
22 |
22 |
$426.13 |
| 86592 |
|
98 |
96 |
$418.38 |
| 86695 |
|
22 |
22 |
$290.76 |
| 84439 |
|
29 |
29 |
$282.38 |
| 87086 |
Culture, bacterial; quantitative colony count, urine |
26 |
25 |
$197.00 |
| 84153 |
|
12 |
12 |
$191.97 |
| 87275 |
|
14 |
14 |
$185.90 |
| 87276 |
|
14 |
14 |
$185.90 |
| 87088 |
|
15 |
15 |
$129.74 |
| 82570 |
|
17 |
15 |
$88.40 |
| 87899 |
|
13 |
13 |
$35.58 |
| 82565 |
|
17 |
15 |
$16.74 |